The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines
Charlaftis, Nikolaos, Suddason, Tesha, Wu, Xuefeng, Anwar, Saba, Karin, Michael, Gallagher, Ewen
Published in The EMBO journal (03.11.2014)
Published in The EMBO journal (03.11.2014)
Get full text
Journal Article
The MEKK 1 PHD ubiquitinates TAB 1 to activate MAPK s in response to cytokines
Charlaftis, Nikolaos, Suddason, Tesha, Wu, Xuefeng, Anwar, Saba, Karin, Michael, Gallagher, Ewen
Published in The EMBO journal (03.11.2014)
Published in The EMBO journal (03.11.2014)
Get full text
Journal Article
Nivolumab and ipilimumab treatment in prostate cancer with an immunogenic signature (NEPTUNES)
Wong, Yien Ning Sophia, Sankey, Peter, Josephs, Debra Hannah, Jones, Robert J, Crabb, Simon J., Beare, Sandy, Duggan, Marian, White, Laura, Charlaftis, Nikolaos, Wheeler, Graham, Linares, Josep, Quezada, Sergio A., Ensell, Leah, Flanagan, Cliona, Kularatne, Bihani Yoshana, Chung, Moon, Pritchard, Colin C., Freeman, Alex, Marafioti, Teresa, Linch, Mark David
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
siRNA high-throughput kinase library screen identifies protein kinase, DNA-activated catalytic polypeptide to play a role in MyD88-induced IFNA2 activation and IL-8 secretion
Charlaftis, Nikolaos, Fearon, Douglas T, Schoenemeyer, Annett, Morley, Peter J
Published in Biotechnology and applied biochemistry (01.01.2012)
Published in Biotechnology and applied biochemistry (01.01.2012)
Get more information
Journal Article